The Institute of Molecular and Translational Therapeutic Strategies (IMTTS) at Hannover Medical School is seeking for a
(Molecular Biology, Biochemistry, Biomedicine, Pharmacy, Veterinary medicine, or similar)
for the project “Investigating long non-coding RNA regulated pathways driving cardiac regeneration”
This transnational cardiovascular research project is settled within the ERA-CVD initiative and funded by the BMBF. It will explore long non-coding RNA (lncRNA)-mediated regulatory pathways that distinguish neonatal from adult hearts. The major goal is to identify novel lncRNAs and to develop therapeutic lncRNA-based strategies to trigger cardiac regeneration after myocardial infarction in vivo in mice.
We are a highly dynamic, productive and internationally well-connected research institute with a strong focus on translational cardiology and in particular therapeutic non-coding RNA biology. We offer a dedicated research team, state-of-the-art equipment and methodology and an overall international and well-funded environment.
We are seeking, starting from June 1st at the earliest, a highly motivated postdoctoral researcher with strong interest in regenerative, cardiac research and non-coding RNA biology (especially long non-coding RNAs). The main tasks will comprise mouse cardiac surgery methods, gene therapy, cardiac phenotyping as well as standard and advanced molecular biology methods. We are looking for a creative team player who is able to independently conduct research.
Preference will be given to application of candidates with experience in cardiovascular disease models; competence in working with animals (FELASA B or equivalent) is a must. Experience in bioinformatics analysis of big data sets and single cell sequencing technology is a plus.
The position is initially limited to 2 years with the possibility of extension. It is a full-time position not suitable for part-time employment. Payment will be based on personal qualifications and requirements according to the agreement of the “Tarifgemeinschaft der Länder” (TV-L).
The MHH is committed to the advancement of women in professional life. Applications from women are therefore particularly welcome. Severely disabled applicants with equal qualifications will be preferred.
Applicants should send a CV, a brief outline of their research experience and interests and two letters of reference by e-mail to email@example.com or by mail until 27.05.2019.
Medizinische Hochschule Hannover
Dr. Christian Bär, Institut für Molekulare und Translationale Therapiestrategien (IMTTS)
OE 8886, Carl-Neuberg-Straße 1, D-30625 Hannover, Germany